Catechol-O-methyltransferase genotype and response to Compensatory Cognitive Training in outpatients with schizophrenia
The catechol-O-methyltransferase (COMT) Val158Met polymorphism is associated with cognitive functioning in schizophrenia and may predict cognitive training outcomes. This study aimed to explore the contribution of COMT genotype in predicting improvement following Compensatory
Cognitive Training (CCT). We conducted mixed factorial analysis of variance to examine COMT genotype as a predictor of response to CCT (i.e. improved cognitive performance) in 41 participants with schizophrenia-spectrum disorders. We also explored the effect of CCT treatment and COMT genotype
on psychiatric symptom severity, functional capacity, and subjective quality of life. Met carrier status did not predict CCT treatment outcomes. COMT genotype may exert only modest effects on cognitive training response. Further research with larger samples is needed to establish genetic predictors
of response to cognitive training.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
SDSU/UCSD Joint Doctoral Program in Clinical Psychology, Department of Psychiatry, University of California San Diego, San Diego, California, USA
Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, California, USA
June 1, 2015